DOSTARLIMAB 50MG/ML DRUG PRODUCT
GlaxoSmithKline UK
Revision date : 2021-07-01
General Information
Revision date
2021-07-01
Product name
DOSTARLIMAB 50MG/ML DRUG PRODUCT
Product Synonyms
JEMPERLI (DOSTARLIMB-GXLY) INJECTION 500 MG/ML * DOSTARLIMAB MONOCLONAL
Icons in SDS
Company Information
Company name
GlaxoSmithKline UK
E-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
None
Section 2
EU Classification
Regulation (EC) No 1272/2008 as amended This mixture does not meet the criteria for classification according to Regulation (EC) 1272/2008 as amended. Hazard summary Caution - Pharmaceutical agent. Direct contact with eyes may cause temporary irritation. See section 11 of the SDS for additional information on health hazards.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
DOSTARLIMAB, water
Hazard pictograms
None.
Signal word
None.
Hazard statements
The mixture does not meet the criteria for classification.
Prevention
Not available.
Response
Not available.
Storage
Not available.
Disposal
Not available.
Supplemental label elements
7.107 % of the mixture consists of component(s) of unknown acute oral toxicity. 7.107 % of the mixture consists of component(s) of unknown acute dermal toxicity. 5 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 7.107 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 7.107 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
